National Bank of Canada FI Acquires Shares of 66,997 Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM)

National Bank of Canada FI bought a new position in Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 66,997 shares of the company’s stock, valued at approximately $1,632,000. National Bank of Canada FI owned approximately 4.11% of Roundhill GLP-1 & Weight Loss ETF at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in OZEM. Cox Capital Mgt LLC acquired a new position in Roundhill GLP-1 & Weight Loss ETF in the fourth quarter worth $933,000. Commonwealth Equity Services LLC grew its position in shares of Roundhill GLP-1 & Weight Loss ETF by 80.4% during the 4th quarter. Commonwealth Equity Services LLC now owns 36,842 shares of the company’s stock valued at $897,000 after buying an additional 16,416 shares during the last quarter. Relyea Zuckerberg Hanson LLC bought a new stake in shares of Roundhill GLP-1 & Weight Loss ETF during the 4th quarter valued at about $276,000. Finally, Embree Financial Group lifted its holdings in Roundhill GLP-1 & Weight Loss ETF by 22.6% in the fourth quarter. Embree Financial Group now owns 10,874 shares of the company’s stock worth $265,000 after acquiring an additional 2,005 shares during the last quarter.

Roundhill GLP-1 & Weight Loss ETF Trading Down 0.8 %

NASDAQ:OZEM opened at $20.67 on Wednesday. The stock has a 50 day moving average of $24.44 and a 200-day moving average of $25.65. The firm has a market capitalization of $32.45 million and a PE ratio of 25.02. Roundhill GLP-1 & Weight Loss ETF has a 52 week low of $20.21 and a 52 week high of $29.21.

Roundhill GLP-1 & Weight Loss ETF Company Profile

The Roundhill GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies from around the world involved in pharmaceutical drugs and supplements used for weight management. OZEM was launched on May 21, 2024 and is issued by Roundhill.